Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment.
Kobayashi M, Suzuki F, Akuta N, Yatsuji H, Hosaka T, Sezaki H, Kobayashi M, Kawamura Y, Suzuki Y, Arase Y, Ikeda K, Mineta R, Iwasaki S, Watahiki S, Kumada H.
Kobayashi M, et al. Among authors: ikeda k.
Hepatol Res. 2010 Feb;40(2):125-34. doi: 10.1111/j.1872-034X.2009.00565.x. Epub 2009 Sep 25.
Hepatol Res. 2010.
PMID: 19788696